Review Article
Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis
Jamal Hallajzadeh 1, Maliheh Khoramdad 2, Nahid Karamzad 3, Amir Almasi-Hashiani 4, Ali Janati 5, Erfan Ayubi 6, Reza Pakzad 7, Mark J.M. Sullman 8, Saeid Safiri 1,9 *
Cited by CrossRef: 23
1- Elasam A, Ahmed M, Ahmed A, Sharif M, Abusham A, Hassan B, Adam I. The prevalence and phenotypic manifestations of polycystic ovary syndrome (PCOS) among infertile Sudanese women: a cross-sectional study. BMC Women's Health. 2022;22(1) [Crossref]
2- Mishra A, Sharma R, Mittal P, Kapoor R, Srivastav S. Evaluating exercise challenge to validate cardiac autonomic dysfunction in lean PCOS phenotype. 2019;30(4) [Crossref]
3- Mohammed S, Elhaj E, Ahmed M, Eltayeb R, Adam I. Peripheral Hematological Parameters in Sudanese Women with Polycystic Ovary Syndrome. CRCM. 2022;11(07):253 [Crossref]
4- Zhao X, Feng X, Zhao X, Jiang Y, Li X, Niu J, Meng X, Wu J, Xu G, Hou L, Wang Y. How to Screen and Prevent Metabolic Syndrome in Patients of PCOS Early: Implications From Metabolomics. Front Endocrinol. 2021;12 [Crossref]
5- 王 亚. Research Progress on the Relationship between Polycystic Ovary Syndrome and Metabolic Syndrome Components. MD. 2024;14(01):124 [Crossref]
6- BAKIR V, KARAHAN G. Evaluation of Obesity and Metabolic Status in Polycystic Ovary Syndrome in Fertile and Infertile Groups. 2019;50(2):44 [Crossref]
7- Ahrenfeldt L, Möller S, Wensink M, Eisenberg M, Christensen K, Jensen T, Lindahl-Jacobsen R. Impaired fecundity as a marker of health and survival: a Danish twin cohort study. 2021;36(8):2309 [Crossref]
8- He F, Li Y. Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review. J Ovarian Res. 2020;13(1) [Crossref]
9- Farhadi-Azar M, Behboudi-Gandevani S, Rahmati M, Mahboobifard F, Khalili Pouya E, Ramezani Tehrani F, Azizi F. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study. Front Endocrinol. 2022;13 [Crossref]
10- Macut D, Mladenović V, Bjekić-Macut J, Livadas S, Stanojlović O, Hrnčić D, Rašić-Marković A, Milutinović D, Andrić Z. Hypertension in Polycystic Ovary Syndrome: Novel Insights. CHYR. 2020;16(1):55 [Crossref]
11- Huang Q, Liu Y, Yang Z, Xie Y, Mo Z. The Effects of Cholesterol Metabolism on Follicular Development and Ovarian Function. CMM. 2019;19(10):719 [Crossref]
12- Hsieh Y, Yang P, Chen M. Metabolic Syndrome in Polycystic Ovary Syndrome. FandR. 2021;03(04):125 [Crossref]
13- Hashemi H, Rezvan F, Pakzad R, Ansaripour A, Heydarian S, Yekta A, Ostadimoghaddam H, Pakbin M, Khabazkhoob M. Global and Regional Prevalence of Diabetic Retinopathy; A Comprehensive Systematic Review and Meta-analysis. Seminars in Ophthalmology. 2022;37(3):291 [Crossref]
14- Balakrishnan P, Jacyshyn-Owen E, Eberl M, Friedrich B, Etter T. Real-world demographic patterns of users of a digital primary prevention service for diabetes. 2022;12(1) [Crossref]
15- Aguaviva Bascuñana J, Olivares Sánchez N. Intervenciones dietéticas en el tratamiento del síndrome del ovario poliquístico. Una revisión bibliográfica. Clínica e Investigación en Ginecología y Obstetricia. 2024;51(1):100911 [Crossref]
16- Slouma M, Ben Ali K, Kharrat L, Zouaoui C, Ouertani H, Gharsallah I. Athrogenic indexes: Useful markers for predicting metabolic syndrome in axial spondyloarthritis. Clínica e Investigación en Arteriosclerosis. 2022;34(5):261 [Crossref]
17- Meng X, Chen B, Liu X, Zhang J, Xie S, Liu L, Wen L, Deng A, Mao Z. Inferring Causal Relationships Between Metabolites and Polycystic Ovary Syndrome Using Summary Statistics from Genome‑Wide Association Studies. Reprod Sci. 2024;31(3):832 [Crossref]
18- Ran Y, Yi Q, Li C. Correlation Between Recovery of Menstrual Cycle and Improvement of Glucose and Lipid Metabolism in Patients with Sleeve Gastrectomy in a Small Chinese Cohort Sample
. DMSO. 2020;Volume 13:4711 [Crossref]
19- Cai J, Yue J, Lu N, Li S, Zheng J, Huang R, Jiang Y, Shan C, Liu W, Ma J, Wang L. Association of Fat Mass and Skeletal Muscle Mass with Cardiometabolic Risk Varied in Distinct PCOS Subtypes: A Propensity Score-Matched Case-Control Study. JCM. 2024;13(2):483 [Crossref]
20- Nagy R, Homminga I, Jia C, Liu F, Anderson J, Hoek A, Tietge U. Trimethylamine-N-oxide is present in human follicular fluid and is a negative predictor of embryo quality. 2020;35(1):81 [Crossref]
21- Slouma M, Ben Ali K, Kharrat L, Zouaoui C, Ouertani H, Gharsallah I. Athrogenic indexes: Useful markers for predicting metabolic syndrome in axial spondyloarthritis. Clínica e Investigación en Arteriosclerosis (English Edition). 2022;34(5):261 [Crossref]
22- Guo H, Luo J, Lin H. Exploration of the pathogenesis of polycystic ovary syndrome based on gut microbiota: A review. 2023;102(50):e36075 [Crossref]
23- Al-Hail N, Butler A, Dargham S, Abou Seif A, Atkin S. Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian Syndrome. Front Endocrinol. 2019;10 [Crossref]
24- Zamora M, Sabado-Liwag M. Mental Health and PCOS Information-Sharing: Interviews with Health Care Providers in a Low-Income Urban Community. J Racial and Ethnic Health Disparities. 2023;10(3):1086 [Crossref]